Optimizing bone health in children and adolescents
NH Golden, SA Abrams, Committee on Nutrition… - …, 2014 - publications.aap.org
The pediatrician plays a major role in helping optimize bone health in children and
adolescents. This clinical report reviews normal bone acquisition in infants, children, and …
adolescents. This clinical report reviews normal bone acquisition in infants, children, and …
New perspectives on osteogenesis imperfecta
A Forlino, WA Cabral, AM Barnes… - Nature Reviews …, 2011 - nature.com
A new paradigm has emerged for osteogenesis imperfecta as a collagen-related disorder.
The more prevalent autosomal dominant forms of osteogenesis imperfecta are caused by …
The more prevalent autosomal dominant forms of osteogenesis imperfecta are caused by …
Bisphosphonate therapy for osteogenesis imperfecta
K Dwan, CA Phillipi, RD Steiner… - Cochrane database of …, 2016 - cochranelibrary.com
Background Osteogenesis imperfecta is caused by a genetic defect resulting in an abnormal
type I collagen bone matrix which typically results in multiple fractures with little or no …
type I collagen bone matrix which typically results in multiple fractures with little or no …
Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases
HZ Ke, WG Richards, X Li, MS Ominsky - Endocrine reviews, 2012 - academic.oup.com
The processes of bone growth, modeling, and remodeling determine the structure, mass,
and biomechanical properties of the skeleton. Dysregulated bone resorption or bone …
and biomechanical properties of the skeleton. Dysregulated bone resorption or bone …
Osteogenesis imperfecta
JC Marini, WA Cabral - Genetics of bone biology and skeletal disease, 2018 - Elsevier
Osteogenesis imperfecta is a genetic disorder characterized by low bone mass, decreased
bone strength, increased bone fragility, and shortened stature. Autosomal dominant …
bone strength, increased bone fragility, and shortened stature. Autosomal dominant …
Osteogenesis imperfecta in children and adolescents—new developments in diagnosis and treatment
P Trejo, F Rauch - Osteoporosis International, 2016 - Springer
Osteogenesis imperfecta (OI) is the most prevalent heritable bone fragility disorder in
children. It has been known for three decades that the majority of individuals with OI have …
children. It has been known for three decades that the majority of individuals with OI have …
Osteogenesis imperfecta–a clinical update
S Tournis, AD Dede - Metabolism, 2018 - Elsevier
Osteogenesis imperfecta (OI) is the most common inherited form of bone fragility and
includes a heterogenous group of genetic disorders which most commonly result from …
includes a heterogenous group of genetic disorders which most commonly result from …
Osteogenesis imperfecta and therapeutics
R Morello - Matrix Biology, 2018 - Elsevier
Osteogenesis imperfecta, or brittle bone disease, is a congenital disease that primarily
causes low bone mass and bone fractures but it can negatively affect other organs. It is …
causes low bone mass and bone fractures but it can negatively affect other organs. It is …
The management of osteoporosis in children
This article reviews the manifestations and risk factors associated with osteoporosis in
childhood, the definition of osteoporosis and recommendations for monitoring and …
childhood, the definition of osteoporosis and recommendations for monitoring and …
[HTML][HTML] Safety and efficacy of denosumab in children with osteogenesis imperfecta-a first prospective trial
H Hoyer-Kuhn, J Franklin, G Allo, M Kron… - … of musculoskeletal & …, 2016 - ncbi.nlm.nih.gov
Objectives: Osteogenesis imperfecta (OI) is a rare hereditary disease leading to bone
fragility. Denosumab as a RANK ligand antibody inhibiting osteoclast maturation has been …
fragility. Denosumab as a RANK ligand antibody inhibiting osteoclast maturation has been …